<TABLE> <S> <C>

<ARTICLE>                     5
<LEGEND>
THE SCHEDULE  CONTAINS SUMMARY  FINANCIAL  INFORMATION  EXTRACTED FROM CONDENSED
CONSOLIDATED BALANCE SHEETS, CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS AND
NOTES TO CONDENSED  CONSOLIDATED  FINANCIAL STATEMENTS REPORTED IN FORM 10-Q FOR
THE PERIOD  ENDED JULY 2, 2000 AND IS  QUALIFIED IN ITS ENTIRETY BY REFERENCE TO
SUCH FINANCIAL STATEMENTS.
</LEGEND>
<CIK>            0000925054
<NAME>           SPECTRIAN CORP /DE/
<MULTIPLIER>     1,000

<S>                                                     <C>
<PERIOD-TYPE>                                           3-MOS
<FISCAL-YEAR-END>                                       MAR-31-2001
<PERIOD-START>                                          APR-01-2000
<PERIOD-END>                                            JUL-02-2000
<CASH>                                                       11,179
<SECURITIES>                                                 31,220<F1>
<RECEIVABLES>                                                27,748
<ALLOWANCES>                                                    420
<INVENTORY>                                                  34,584
<CURRENT-ASSETS>                                            110,473
<PP&E>                                                       68,380
<DEPRECIATION>                                               49,400
<TOTAL-ASSETS>                                              130,721
<CURRENT-LIABILITIES>                                        33,108
<BONDS>                                                         959
<PREFERRED-MANDATORY>                                             0
<PREFERRED>                                                       0
<COMMON>                                                         12
<OTHER-SE>                                                   96,642
<TOTAL-LIABILITY-AND-EQUITY>                                130,721
<SALES>                                                      42,190
<TOTAL-REVENUES>                                             42,190
<CGS>                                                        35,268
<TOTAL-COSTS>                                                35,268
<OTHER-EXPENSES>                                              5,601<F2>
<LOSS-PROVISION>                                                  0
<INTEREST-EXPENSE>                                               46
<INCOME-PRETAX>                                              (3,788)
<INCOME-TAX>                                                     12
<INCOME-CONTINUING>                                          (3,800)
<DISCONTINUED>                                                    0
<EXTRAORDINARY>                                                   0
<CHANGES>                                                         0
<NET-INCOME>                                                 (3,800)
<EPS-BASIC>                                                   (0.35)<F3>
<EPS-DILUTED>                                                 (0.35)
<FN>
<F1> Securities,  Item  5-02(2),  are net of accrued  interest  and  unrealized gain/loss.
<F2> Item consists of research and development.
<F3> Item consists of basic earnings per share.
</FN>


</TABLE>